Hutchin Hill Capital’s Celgene Corp CELG Stock Holding History

Hutchin Hill Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,500	Closed	-$311K	–	1218
2017 Q1	$311K	Buy	+2,500	New	+$299K	0.01%	795
2015 Q2	–	Sell	-48,600	Closed	-$5.6M	–	949
2015 Q1	$5.6M	Buy	+48,600	New	+$5.81M	0.16%	135
2014 Q2	–	Sell	-129,800	Closed	-$9.06M	–	870
2014 Q1	$9.06M	Buy	+129,800	New	+$10.3M	0.47%	46
2013 Q3	–	Sell	-13,000	Closed	-$760K	–	687
2013 Q2	$760K	Buy	+13,000	New	+$782K	0.08%	206

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hutchin Hill Capital's CELG Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 2,500 shares — an estimated $311K sold.

Hutchin Hill Capital first reported a position in CELG in Q2 2013 and held it in 4 quarters. The position peaked at $9.06M in Q1 2014. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Hutchin Hill Capital reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
Hutchin Hill Capital sold 2,500 Celgene Corp shares in Q2 2017, an estimated $311K.
Hutchin Hill Capital first reported a position in Celgene Corp in Q2 2013 and held it in 4 quarters.
Hutchin Hill Capital's Celgene Corp position peaked at $9.06M in Q1 2014.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.